The partnership builds on Novo Nordisk journey for more automated and digital workstreams in their CMC Laboratories.
Techvolver is thrilled to announce a new partnership with Novo Nordisk®.
The partnership builds on Novo Nordisk journey for more automated and digital workstreams in their CMC Laboratories. For this, we are delighted that the potential in our automated pipette calibration solution, Calvolver, has been identified by Novo Nordisk and that bold steps have been taken to set up this strategic partnership.
Through this initiative, Novo Nordisk will now perform pipette calibration in-house with a reduced risk of error due to minimized human handling. The entire process runs automatically, with pipettes being calibrated over-night and all data transferred digitally to their LIMS or QC systems without needing manual handling.
“The process of getting started has been based on an open dialogue between our two businesses. We see ourselves as a service provider who simply wants to implement and support automated processes in laboratories. Ultimately, it is about freeing up lab technicians to work on value-adding activities rather than tedious, repetitive work. We have made automated calibration available for everyone”, says Jakob F. Skjærlund, Co-Founder & CEO, Techvolver.
“At Techvolver, we live to solve challenges that help businesses sustain growth and improve work-life. We look forward to collaborating with Novo Nordisk® on how to optimize their lab automation while continuing to learn and adapt based on their vast knowhow”, says Jakob.
